Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey
Choosing between Sunlight and Gala GLP-1 for GLP-1 weight loss medication? Both are popular providers, but they differ in pricing, medication options, and service features.
Sunlight offers both semaglutide and tirzepatide at $88/month with a rating of 7.5/10. Gala GLP-1 also provides both semaglutide and tirzepatide at $149/month with a 7.5/10 rating.
The price difference of $61/month is significant - Sunlight is the more budget-friendly option, while Gala GLP-1 positions itself as a premium service.
After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.
| Feature | Sunlight | Gala GLP-1 |
|---|---|---|
| Monthly Price | $88 | $149 |
| Rating | 7.5/10 | 7.5/10 |
| Medications | semaglutide, tirzepatide | semaglutide, tirzepatide |
| Insurance Accepted | No | No |
| Support Hours | Not published | 7 days a week (hours not published) |
| Live Chat | No | No |
| Free Shipping | Yes | Yes |
| Shipping Speed | Free shipping in 1-2 days claimed | Free 2-day shipping claimed |
| Mobile App | No | No |
| Dedicated Coach | Not included | Included |
| Follow-up Frequency | Unlimited telehealth visits included | Ongoing 1:1 care from provider and support team |
| Money-back Guarantee | Refund of unused months and the video visit fee if a provider medically disqualifies you | Full refund only if a provider disqualifies you; otherwise the policy states no refund will be issued on cancellation |
| Cancellation Policy | Cancel any time; flat pricing promised with no advertised minimum term | Cancel anytime with at least 72 hours notice before your billing date; refunds only for the most recent billing cycle |

